Found: 115
Select item for more details and to access through your institution.
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- letter
Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- letter
Molecular Assay-Based Extragenital Screening for Chlamydia Trachomatis and Neisseria Gonorrhoeae in Men Who Have Sex with Men.
- Published in:
- Archives of Sexual Behavior, 2024, v. 53, n. 9, p. 3309, doi. 10.1007/s10508-024-02978-3
- By:
- Publication type:
- Article
Liver fibrosis is associated with cognitive impairment in people living with HIV.
- Published in:
- Infection, 2019, v. 47, n. 4, p. 589, doi. 10.1007/s15010-019-01284-8
- By:
- Publication type:
- Article
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.
- Published in:
- Infection, 2017, v. 45, n. 4, p. 521, doi. 10.1007/s15010-017-1018-z
- By:
- Publication type:
- Article
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned?
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 4, p. 417, doi. 10.3390/healthcare12040417
- By:
- Publication type:
- Article
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae198
- By:
- Publication type:
- Article
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad526
- By:
- Publication type:
- Article
Shall We Dance? Extending TANGO's Results to Clinical Practice.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort.
- Published in:
- HIV Medicine, 2021, v. 22, n. 9, p. 843, doi. 10.1111/hiv.13146
- By:
- Publication type:
- Article
'How much raltegravir do you take?' The answer may not be so obvious: an accidental finding from clinical practice.
- Published in:
- HIV Medicine, 2020, v. 21, n. 2, p. e1, doi. 10.1111/hiv.12783
- By:
- Publication type:
- Article
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV.
- Published in:
- Journal of NeuroVirology, 2022, v. 28, n. 3, p. 422, doi. 10.1007/s13365-022-01078-z
- By:
- Publication type:
- Article
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.
- Published in:
- Journal of NeuroVirology, 2020, v. 26, n. 6, p. 899, doi. 10.1007/s13365-020-00891-8
- By:
- Publication type:
- Article
Hepatitis C virus–related factors associated WITH cognitive performance in HIV-HCV-coinfected patients.
- Published in:
- Journal of NeuroVirology, 2019, v. 25, n. 6, p. 866, doi. 10.1007/s13365-019-00780-9
- By:
- Publication type:
- Article
Determinants of SARS-COV-2 seroconversion in a cohort of recovered patients.
- Published in:
- Infezioni in Medicina, 2021, v. 29, n. 1, p. 163
- By:
- Publication type:
- Article
Psychological distress during the initial stage of the COVID-19 pandemic in an Italian population living with HIV: an online survey.
- Published in:
- Infezioni in Medicina, 2021, v. 29, n. 1, p. 54
- By:
- Publication type:
- Article
Comparison of HIV-DNA decay in naïve patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy.
- Published in:
- Infezioni in Medicina, 2020, v. 28, n. 3, p. 461
- By:
- Publication type:
- Article
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study.
- Published in:
- Infezioni in Medicina, 2019, v. 27, n. 4, p. 410
- By:
- Publication type:
- Article
Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population.
- Published in:
- Infezioni in Medicina, 2019, v. 27, n. 3, p. 274
- By:
- Publication type:
- Article
Kaposi-like manifestations in a newly diagnosed AIDS transgendered patient with silicone embolism syndrome and disseminated tuberculosis.
- Published in:
- Infezioni in Medicina, 2019, v. 27, n. 2, p. 190
- By:
- Publication type:
- Article
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice.
- Published in:
- Infezioni in Medicina, 2018, v. 26, n. 4, p. 336
- By:
- Publication type:
- Article
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV.
- Published in:
- Psychological Reports, 2023, v. 126, n. 3, p. 1181, doi. 10.1177/00332941211057142
- By:
- Publication type:
- Article
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab103
- By:
- Publication type:
- Article
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors.
- Published in:
- Open Forum Infectious Diseases, 2015, v. 2, n. 2, p. 1, doi. 10.1093/ofid/ofv043
- By:
- Publication type:
- Article
Comparative determination of HIV-1 co-receptortropism by Enhanced Sensitivity Trofile, gp120V3-loop RNA and DNA genotyping.
- Published in:
- Retrovirology, 2010, v. 7, p. 56, doi. 10.1186/1742-4690-7-56
- By:
- Publication type:
- Article
COVID‐19 diagnosis does not rule out other concomitant diseases.
- Published in:
- European Journal of Clinical Investigation, 2020, v. 50, n. 6, p. 1, doi. 10.1111/eci.13241
- By:
- Publication type:
- Article
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study.
- Published in:
- AIDS Patient Care & STDs, 2022, v. 36, n. 5, p. 178, doi. 10.1089/apc.2022.0030
- By:
- Publication type:
- Article
Reporting a single case of cystic echinococcosis in retroperitoneal mass of uncertain origin.
- Published in:
- Parasitology Research, 2024, v. 123, n. 1, p. 1, doi. 10.1007/s00436-023-08018-8
- By:
- Publication type:
- Article
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 3, p. 735
- By:
- Publication type:
- Article
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression ...
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1364, doi. 10.1093/jac/dkt007
- By:
- Publication type:
- Article
Mortality in patients with early- or late-onset candidaemia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 4, p. 927, doi. 10.1093/jac/dks480
- By:
- Publication type:
- Article
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 1, p. 200
- By:
- Publication type:
- Article
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 4, p. 984, doi. 10.1093/jac/dkr581
- By:
- Publication type:
- Article
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 8, p. 1886
- By:
- Publication type:
- Article
Lipid-lowering effect of tenofovir in HIV-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 3, p. 682, doi. 10.1093/jac/dkq464
- By:
- Publication type:
- Article
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 3, p. 616, doi. 10.1093/jac/dkp252
- By:
- Publication type:
- Article
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 1, p. 109, doi. 10.1093/jac/dkp132
- By:
- Publication type:
- Article
Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 1, p. 39, doi. 10.3390/diagnostics12010039
- By:
- Publication type:
- Article
Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1154, doi. 10.3390/diagnostics11071154
- By:
- Publication type:
- Article
HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 4, p. 2051, doi. 10.1007/s40121-021-00522-7
- By:
- Publication type:
- Article
The association between stigma and wellbeing in an Italian cohort of PLWH: The role of social support and personal factors.
- Published in:
- International Journal of STD & AIDS, 2024, v. 35, n. 3, p. 176, doi. 10.1177/09564624231213115
- By:
- Publication type:
- Article
Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013753
- By:
- Publication type:
- Article
The Threshold Bootstrap Clustering: A New Approach to Find Families or Transmission Clusters within Molecular Quasispecies.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013619
- By:
- Publication type:
- Article
A Randomized Controlled Trial to Evaluate Antiretroviral Salvage Therapy Guided by Rules-Based or Phenotype-Driven HIV-1 Genotypic Drug-Resistance Interpretation With or Without Concentration-Controlled Intervention: The Resistance and Dosage Adapted...
- Published in:
- Clinical Infectious Diseases, 2005, v. 40, n. 12, p. 1828
- By:
- Publication type:
- Article
Effect of Aging and Human Immunodeficiency Virus Infection on Cognitive Abilities.
- Published in:
- Journal of the American Geriatrics Society, 2012, v. 60, n. 11, p. 2048, doi. 10.1111/j.1532-5415.2012.04213.x
- By:
- Publication type:
- Article
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three‐drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 10, p. 1, doi. 10.1002/jmv.29149
- By:
- Publication type:
- Article